Trulieve Cannabis is trading 4.83% down now at $11.09 after no clear company-specific catalyst emerged in available September 18, 2026 coverage.
- Recent company news consists of September event participation and the Dunwoody, Georgia, dispensary opening; neither directly explains today’s decline.
- The broader market is modestly weaker, but its move is too limited to clearly explain the sharper drop.
- The reason remains uncertain and should be rechecked for delayed news.